Global Vaccine Adjuvants Market
An adjuvant is defined as the substance which is formulated as a part of vaccine to enhance its ability to induce protection against infection. It supports to activate immune system & permit the antigens pathogen constituents that cause an immune response in vaccines to prompt long period protective immunity. Aluminum hydroxide & paraffin oil are most commonly used adjuvants.
Market Drivers
The increase in prevalence of cervical cancer, infectious diseases like Human Papillomavirus (HPV), HIV, tuberculosis, etc., and other fatal diseases are expected to drive the global vaccine adjuvants market. Furthermore, the increase support of government in research & development, high incidences of epidermic outbreaks as well as tactical development interchanges adopted by companies like acquisitions, agreements, and collaborations are accelerating the global vaccine adjuvants market growth. For instance, in 2017, USFDA (Food and Drug Administration) had approved Nerlynx a product of Puma Biotechnology Inc. for adjuvant treatment of breast cancer.
Furthermore, the increase in focus on the long-lasting effect of immunization against existing and emerging diseases will positively influence the market growth. The importance of adjuvant research for the development of these products has raised significantly owing to the inadequate immunogenicity of innovative vaccine antigens. Also, the rise in use of recombinant and synthetic vaccines is expected to support the market growth throughout the forecast period.
Market Restraints
High toxicity of adjuvants on application, huge investment required for developing a new adjuvant and strict regulatory requirements are some restraining factors which are expected to hamper the global vaccine adjuvants market growth. For instance, according to the information published Scientific Reports Journal revealed the toxicity of aluminum adjuvants in clinically approved various human vaccinations, in 2016.
Market Segmentation
On the basis of type, the global vaccine adjuvants market is segmented into a Pathogen, Adjuvant Emulsion, Combination, Particulate, and Others. The particulate type is expected to hold the largest market share in vaccine adjuvants market. Due to the availability of a wide range of products and greater efficiency against the diseases. Further, market is segmented into route of administration such as Oral, Intranasal, Intramuscular, Intradermal, and Others. The intramuscular segment accounted for the largest market share in due to better immune specificity. On other hand, the market is segmented into application such as Infectious Disease, Cancer, and Others.
Impact of COVID-19
The increase in COVID-19 outbreak is expected to drive the global vaccine adjuvants market. Due to the crisis, majority of healthcare, pharmaceutical as well as biotechnology organizations have concentrated on treatment, vaccines and medication against Novel coronavirus. Most of the leading companies are focusing on finding a breakthrough vaccine against COVID-19. Furthermore, pharmaceutical companies are prioritizing R&D of COVID-19 elated diagnostics, treatments, and vaccines. All these factors are expected to contribute the global vaccine adjuvants market growth over the forecast period.
Regional Analysis
Global Vaccine Adjuvants Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America region holds the dominant position in global vaccine adjuvants market in terms of revenue, due to high adoption of the innovative products and presence of major market players in this region especially in the United States. Further, favorable government support towards the growth of healthcare infrastructure is also contribute the growth of the vaccine adjuvants market in this region. Moreover, the APAC was estimated to be the fastest growing market owing to the continuously improving healthcare facilities such as the availability of medicines, coupled with the increase in research & development funding to meet the huge unmet demands. This is expected to increase the market share over the forecast period.
Key Players
Some of the key players are listed in this report such as Novavax, Inc., GlaxoSmithKline plc., Puma Biotechnology, SEPPIC Inc., Aphios, OZ Biosciences, Agenus,Inc., Hayashibara Co., Ltd., Invivogen, MPV Technologies, etc. These companies are adopting strategies like collaborations, mergers & acquisitions, and new product development. For instance, in July 2017, GSK had collaborated with Exscientia for the development of new drugs.
Market Taxonomy
By Type
By Route of Administration
By Application
By Region
Key Questions Addressed by the Report
Global Vaccine Adjuvants Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Vaccine Adjuvants Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Vaccine Adjuvants Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Vaccine Adjuvants Market Share Analysis, By Type
5.3 Global Vaccine Adjuvants Market Size and Forecast, By Type
5.3.1 Pathogen
5.3.2. Adjuvant Emulsion
5.3.3. Combination
5.3.4. Particulate
5.3.5. Others
6 Global Vaccine Adjuvants Market, By Route of Administration
6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Vaccine Adjuvants Market Share Analysis, By Route of Administration
6.3 Global Vaccine Adjuvants Market Size and Forecast, By Route of Administration
6.3.1 Oral
6.3.2 Intranasal
6.3.3 Intramuscular
6.3.4 Intradermal
6.3.5. Others
7 Global Vaccine Adjuvants Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Vaccine Adjuvants Market Share Analysis, By Application
7.3 Global Vaccine Adjuvants Market Size and Forecast, By Application
7.3. 1 Infectious Disease
7.3.2. Cancer
7.3.3. Others
8Global Vaccine Adjuvants Market, By Region
8.1 Global Vaccine Adjuvants Market Share Analysis, By Region
8.2 Global Vaccine Adjuvants Market Share Analysis, By Region
8.3 Global Vaccine Adjuvants Market Size and Forecast, By Region
9 North America Vaccine Adjuvants Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Vaccine Adjuvants Market Share Analysis, By Type
9.3 North America Vaccine Adjuvants Market Size and Forecast, By Route of Administration
9.4 North America Vaccine Adjuvants Market Size and Forecast, By Application
9.5 North America Vaccine Adjuvants Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeVaccine Adjuvants Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Vaccine Adjuvants Market Share Analysis, By Type
10.3 Europe Vaccine Adjuvants Market Size and Forecast, By Route of Administration
10.4 Europe Vaccine Adjuvants Market Size and Forecast, By Application
10.5 Europe Vaccine Adjuvants Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Vaccine Adjuvants Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Vaccine Adjuvants Market Share Analysis, By Type
11.3 Asia Pacific Vaccine Adjuvants Market Size and Forecast, By Route of Administration
11.4 Asia Pacific Vaccine Adjuvants Market Size and Forecast, By Application
11.5 Asia Pacific Vaccine Adjuvants Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Vaccine Adjuvants Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Vaccine Adjuvants Market Share Analysis, By Type
12.3 Latin America Vaccine Adjuvants Market Size and Forecast, By Route of Administration
12.4 Latin America Vaccine Adjuvants Market Size and Forecast, By Application
12.5 Latin America Vaccine Adjuvants Market Size and Forecast, Country
13Middle East Vaccine Adjuvants Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Vaccine Adjuvants Market Share Analysis, By Type
13.3 Middle East Vaccine Adjuvants Market Size and Forecast, By Route of Administration
13.4 Middle East Vaccine Adjuvants Market Size and Forecast, By Application
13.5 Middle East Vaccine Adjuvants Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Novavax, Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. GlaxoSmithKline plc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Puma Biotechnology
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 SEPPIC Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Aphios
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 OZ Biosciences
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Agenus,Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Hayashibara Co., Ltd
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Invivogen
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Invivogen
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
